Pfizer (PFE) Tops Q4 EPS by 1c; Reports $5B Buyback; Guides FY11, Raises FY12 Outlook
Tweet Send to a Friend
Pfizer Inc. (NYSE: PFE) reported Q4 EPS of $0.47, $0.01 better than the analyst estimate of $0.46 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
